eIF2α dephosphorylation inhib 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
  • ||||||||||  icerguastat (IFB-088) / InFlectis
    Integrated Stress Response in alpha synucleinopathy (WCC Halls A-C) -  Nov 3, 2023 - Abstract #Neuroscience2023NEUROSCIENCE_11540;    
    pathway is an important pathological axis for ?-synucleinopathy and different phosphatases are differentially involved in various neurodegenerative conditions. Moreover, we show that ISR components, particularly inhibition of CReP, is a therapeutic target for ?-synucleinopathy.
  • ||||||||||  salubrinal / Soochow University
    Review, Journal:  ER Stress, the Unfolded Protein Response and Osteoclastogenesis: A Review. (Pubmed Central) -  Aug 2, 2023   
    expression) directly inhibited osteoclastogenesis by suppressing NFATc1 expression and indirectly promoted osteoclastogenesis by promoting RANKL secretion from osteoblasts...In addition, the exact role of ATF6 and BiP in osteoclastogenesis also required further exploration. In conclusion, our detailed and systematic review provides some references for the next step to fully elucidate the relationship between UPR and osteoclastogenesis, intending to provide new insights for the treatment of diseases caused by osteoclast over-differentiation, such as osteoporosis.
  • ||||||||||  Zolinza (vorinostat) / Merck (MSD), salubrinal / Soochow University
    Journal, PARP Biomarker:  Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant. (Pubmed Central) -  Sep 14, 2022   
    Finally, PED-GBM was more sensitive than normal human astrocytes to salubrinal, raphin-1, and the treatment combinations described herein. Our results indicate that combinations of histone deacetylase inhibitors and PARP-1 inhibitors should be evaluated for their toxicity and efficacy in PED-GBM patients and point to drugs that increase P-eIF2α or modulate its downstream effectors as a novel means of treating PED-GBM.
  • ||||||||||  Journal:  Upregulation of tRNA-Ser-AGA-2-1 Promotes Malignant Behavior in Normal Bronchial Cells. (Pubmed Central) -  May 20, 2022   
    Futhermore, tRNA(AGA) enhanced transformation potential in vitro, and promoted the establishment of slow growing tumors with aggressive features in nude mice. Our work highlights the importance of studying tRNA deregulation on early stage tumorigenesis, as they may be potential malignancy and aggressiveness biomarkers.
  • ||||||||||  Journal:  An Overview of Methods for Detecting eIF2α Phosphorylation and the Integrated Stress Response. (Pubmed Central) -  Feb 23, 2022   
    However, despite more than two decades of research and growing pharmacological interest, phosphorylation of eIF2α remains difficult to detect and quantify, because of its transient nature and because substoichiometric amounts of this modification are sufficient to profoundly reshape cellular physiology. This review aims to provide a roadmap for facilitating a robust evaluation of eIF2α phosphorylation and its downstream consequences in cells and organisms.
  • ||||||||||  salubrinal / Soochow University
    Journal:  GADD34-mediated dephosphorylation of eIF2α facilitates pseudorabies virus replication by maintaining de novo protein synthesis. (Pubmed Central) -  Jan 29, 2022   
    An increase in the eIF2α phosphorylation level by salubrinal treatment or transfection of constructs expressing wild-type eIF2α or an eIF2α phosphomimetic [eIF2α(S51D)] attenuated global protein synthesis and suppressed PRV replication...Knockdown of GADD34 and inhibition of PP1 activity by okadaic acid treatment led to increased eIF2α phosphorylation but significantly suppressed global protein synthesis and inhibited PRV replication. Collectively, these results demonstrated that PRV induces GADD34 expression to promote eIF2α dephosphorylation, thereby maintaining de novo protein synthesis and facilitating viral replication.
  • ||||||||||  salubrinal / Soochow University
    Journal:  eIF2α-ATF4 Pathway Activated by a Change in the Calcium Environment Participates in BCP-Mediated Bone Regeneration. (Pubmed Central) -  Aug 4, 2021   
    An inhibitor of eIF2α dephosphorylation (salubrinal) was also used to explore the effect of the eIF2α-ATF4 pathway on BCP-mediated bone regeneration...In conclusion, the eIF2α-ATF4 pathway activated by a change in the calcium environment participates in BCP-mediated bone regeneration. eIF2α-ATF4 and ERs could provide new directions for further studies on new materials in bone tissue engineering.
  • ||||||||||  salubrinal / Soochow University
    Journal:  Pseudorabies virus infection inhibits stress granules formation via dephosphorylating eIF2α. (Pubmed Central) -  May 15, 2021   
    Moreover, inhibition of PP1 activity by salubrinal could counteract PRV-mediated eIF2α dephosphorylation partially and inhibit virus replication. Our results revealed that, on the one hand, PRV infection activated eIF2α kinases PKR (latter inhibited) and PERK, and on the other hand, PRV encoded-functions dephosphorylated eIF2α and inhibited SGs formation to facilitate virus replication.